Construction of an adenovirus type 7a E1A- vector

Area of Science:

• * Virology
• * Molecular Biology
• * Gene Therapy

Background:

• * Adenovirus vectors are widely used for gene therapy.
• * Subgroup C adenoviruses (e.g., Ad5) are common but have limitations.
• * Non-subgroup C adenoviruses offer potential advantages for vector development.

Purpose of the Study:

• * To develop a replication-defective adenovirus vector from a non-subgroup C virus.
• * To demonstrate the feasibility of using adenovirus type 7 strain a (Ad7a) for gene transfer.
• * To characterize the in vitro and in vivo performance of the novel Ad7a vector.

Main Methods:

• * Construction of an E1A-deleted Ad7a reporter virus (Ad7a-CAT) using Ad7a DNA, a reporter plasmid, and 293 cells.
• * In vitro transduction of A549 cells to assess viral efficiency.
• * Intravenous administration in a murine model to evaluate tissue tropism and transgene expression kinetics.

Main Results:

• * Ad7a-CAT virus particles transduced A549 cells with efficiency comparable to Ad5-based vectors.
• * Intravenous infection in mice showed Ad7a-CAT targeted various tissues, with highest chloramphenicol acetyltransferase (CAT) gene expression in the liver.
• * Transgene expression in the liver was sustained for up to 2 weeks post-infection.

Conclusions:

• * A novel, replication-defective E1A-deleted adenovirus type 7 strain a (Ad7a) gene transfer vector was successfully constructed.
• * This Ad7a-CAT vector demonstrates efficient gene transfer and tissue-specific expression in vivo.
• * This represents the first E1A-deleted adenovirus gene transfer vector derived from a non-subgroup C adenovirus.